fluoxetine

(redirected from Symbyax)
Also found in: Dictionary, Thesaurus.

fluoxetine

 [floo-ok´sĕ-tēn]
a selective serotonin reuptake inhibitor administered orally as the hydrochloride salt as an antidepressant and in the treatment of obsessive-compulsive disorder, bulimia nervosa, and premenstrual dysphoric disorder.

fluoxetine

/flu·ox·e·tine/ (floo-ok´sĕ-tēn) a selective serotonin reuptake inhibitor used as the hydrochloride salt in the treatment of depression, obsessive-compulsive disorder, bulimia nervosa, and premenstrual dysphoric disorder.

fluoxetine

(flo͞o′ŏk′sĭ-tēn′)
n.
A drug of the SSRI class, C17H18F3NO, used in its hydrochloride form to treat depression, obsessive-compulsive disorder, panic disorder, premenstrual dysphoric disorder, and certain eating disorders.

fluoxetine

Prozac® Neuropharmacology A selective inhibitor of serotonin reuptake used for clinical depression and other psychiatric disorders Adverse effects Anxiety, nervousness, tremor, insomnia, diarrhea, nausea, anorexia, undesired weight loss, sexual dysfunction Contraindications MAOI therapy. See Serotonin-selective reuptake inhibitor.

fluoxetine

An antidepressant drug that acts by prolonging the action of the NEUROTRANSMITTER 5-hydroxytryptamine (5HT or serotonin). It is a SELECTIVE SEROTONIN RE-UPTAKE INHIBITOR. It is taken by mouth. This drug is currently being taken by some 10 million people, mainly in the USA, and is said to be the most popular psychoactive drug in the history of pharmacology. It has attracted a great deal of attention as a ‘mood brightener’ and enhancer of optimism. It is claimed to be capable of altering personality for the better. Possible side effects include nausea, vomiting, diarrhoea, insomnia, anxiety, outbursts of violence, fever, skin rash and convulsions. This drug can interact dangerously, even fatally, with MAOIs. A brand name is Prozac.

Fluoxetine

Prozac; the first SSRI; marketed as Sarafem for treating PMDD.

fluoxetine

(flŏŏok´sətēn´),
n brand name: Prozac;
drug class: antidepressant;
action: inhibits CNS neuron uptake of serotonin but not norepinephrine;
use: depressive disorders.

fluoxetine

a serotonin inhibitor, used as an antidepressant. Called also Prozac.
References in periodicals archive ?
One he ad-to-head trial of Symbyax and lamotrigine suggested that 12 patients would need to be treated with Symbyax to give 1 patient benefits greater than those seen with lamotrigine.
Symbyax is fine to use for 6-8 weeks, but no one knows if long-term use might destabilize patient mood.
Symbyax is marketed by Lilly USA and is approved for the acute treatment of treatment-resistant depression and bipolar I depression in adults.
The combination product was approved by the Food and Drug Administration in December and is marketed under the brand name of Symbyax, by Eli Lilly & Co.
The program (and that of its partners) has yielded the commercialization of Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris, and Yentreve over the past five years.
Such major products in established lines as Gemzar, an anticancer drug, and Humalog, an injectable insulin, should perform well, and sales increases are also expected from such newer products as Forteo for severe osteoporosis; Alimta, an oncology agent; Symbyax for bipolar depression; and Cymbalta, an antidepressant.
Nausea and diarrhea are more common with Symbyax therapy.
Lurasidone * Latuda Mirtazapine * Remeron Moclobemide * Amira, Aurorix, Clobemix, Depnil, Manerix Modafinil * Provigil Olanzapine/fluoxetine * Symbyax Paroxetine * Paxil Phenelzine * Nardil Pramipexole * Mirapex Quetiapine * Seroquel Riluzole * Rilutek Sertraline * Zoloft Vortioxetine * Brintellix
The product offering includes the pharmaceuticals launched over the past four years, specifically Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris, and Yentreve, which collectively generated $3.
He led the efforts resulting in the launch and/or product lifecycle of several important neuroscience products, including the antidepressant Prozac, Strattera for attention-deficit (ADHD), Symbyax for bipolar depression, Cymbalta for major depression/ neuropathic pain, and the psychotropic Zyprexa (including a series of line extensions).